SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001682852-20-000010
Filing Date
2020-05-07
Accepted
2020-05-07 16:03:56
Documents
83
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q moderna10-q3312020.htm   iXBRL 10-Q 2316961
2 EXHIBIT 31.1 exhibit3113312020.htm EX-31.1 11352
3 EXHIBIT 31.2 exhibit3123312020.htm EX-31.2 10437
4 EXHIBIT 32.1 exhibit3213312020.htm EX-32.1 14610
10 PIPELINE developmentpipeline.jpg GRAPHIC 173444
11 CELL MAP modernacellmap.jpg GRAPHIC 103491
12 LOGO modernalogoa04.jpg GRAPHIC 63925
  Complete submission text file 0001682852-20-000010.txt   11322790

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrna-20200331.xsd EX-101.SCH 69580
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mrna-20200331_cal.xml EX-101.CAL 92299
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mrna-20200331_def.xml EX-101.DEF 332608
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrna-20200331_lab.xml EX-101.LAB 864973
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrna-20200331_pre.xml EX-101.PRE 527819
28 EXTRACTED XBRL INSTANCE DOCUMENT moderna10-q3312020_htm.xml XML 2002119
Mailing Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 6177146500
Moderna, Inc. (Filer) CIK: 0001682852 (see all company filings)

IRS No.: 813467528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38753 | Film No.: 20856237
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences